Quinolones and Osteomyelitis: State-of-the-art

Overview

Journal Drugs

Specialty Pharmacology

Date 1995 Jan 1

PMID 8549277

Citations 8

Authors

D P Lew

F A Waldvogel

Affiliations

Soon will be listed here.

Abstract

The present review provides a critical quantitative analysis of the use of quinolones in osteomyelitis. Only papers published in peer-reviewed journals and related to the following areas were selected: experimental osteomyelitis, penetration of quinolones into human bone and clinical use in comparative and non-comparative studies. Cumulated results show clinical success rates of more than 90% in osteomyelitis caused by Enterobacteriaceae, after prolonged oral use of ciprofloxacin. However, further comparative studies using oral quinolones as single agents or in combination (versus standard parenteral therapy) are required in osteomyelitis due to S. aureus or P. aeruginosa, or in more complicated situations such as diabetic osteomyelitis or foreign body infection.

Citing Articles

Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial.

Obremskey W, OToole R, Morshed S, Tornetta 3rd P, Murray C, Jones C JAMA Surg. 2025; 160(3):276-284.

PMID: 39841468 PMC: 11904729. DOI: 10.1001/jamasurg.2024.6439.

Molecular characterization of α-amylase from Staphylococcus aureus.

Lakshmi H, Prasad U, Yeswanth S, Swarupa V, Prasad O, Narasu M Bioinformation. 2013; 9(6):281-5.

PMID: 23559746 PMC: 3607186. DOI: 10.6026/97320630009281.

The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes.

Graham S, Fishlock A, Millner P, Sandoe J Eur Spine J. 2013; 22(8):1845-53.

PMID: 23543389 PMC: 3731498. DOI: 10.1007/s00586-013-2750-4.

Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.

Koort J, Makinen T, Suokas E, Veiranto M, Jalava J, Knuuti J Antimicrob Agents Chemother. 2005; 49(4):1502-8.

PMID: 15793132 PMC: 1068592. DOI: 10.1128/AAC.49.4.1502-1508.2005.

Long Bone Osteomyelitis.

Lazzarini L, de Lalla F, Mader J Curr Infect Dis Rep. 2002; 4(5):439-445.

PMID: 12228032 DOI: 10.1007/s11908-002-0012-4.

References

Henry N, Rouse M, Whitesell A, McConnell M, Wilson W . Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am J Med. 1987; 82(4A):73-5. View

Nix D, Cumbo T, Kuritzky P, DeVito J, Schentag J . Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Am J Med. 1987; 82(4A):146-53. View

Norden C, Nelson J, Mader J, Calandra G . Evaluation of new anti-infective drugs for the treatment of infectious arthritis in adults. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992; 15 Suppl 1:S167-71. DOI: 10.1093/clind/15.supplement_1.s167. View

Meissner A, Borner K, Koeppe P . Concentrations of ofloxacin in human bone and in cartilage. J Antimicrob Chemother. 1990; 26 Suppl D:69-74. DOI: 10.1093/jac/26.suppl_d.69. View

Mader J, Norden C, Nelson J, Calandra G . Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992; 15 Suppl 1:S155-61. DOI: 10.1093/clind/15.supplement_1.s155. View

Dellamonica P, Bernard E, Mondain V, Durant J, Argenson C . Pefloxacin in the treatment of bone infections associated with foreign material. J Antimicrob Chemother. 1990; 26 Suppl B:199-205. DOI: 10.1093/jac/26.suppl_b.199. View

Wittmann D, Kotthaus E . Further methodological improvement in antibiotic bone concentration measurements: penetration of ofloxacin into bone and cartilage. Infection. 1986; 14 Suppl 4:S270-3. DOI: 10.1007/BF01661291. View

Hoogkamp-Korstanje J, van Bottenburg H, Van Bruggen J, Davidson J, DETMAR S, De Graaf W . Treatment of chronic osteomyelitis with ciprofloxacin. J Antimicrob Chemother. 1989; 23(3):427-32. DOI: 10.1093/jac/23.3.427. View

Meissner A, Borner K . [Concentration of ciprofloxacin in bone tissue]. Aktuelle Traumatol. 1993; 23(2):80-4. View

10.

Hessen M, Levison M . Ciprofloxacin for the treatment of osteomyelitis: a review. J Foot Surg. 1989; 28(2):100-5. View

11.

Greenberg R, Kennedy D, Reilly P, Luppen K, Weinandt W, Bollinger M . Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin. Antimicrob Agents Chemother. 1987; 31(2):151-5. PMC: 174681. DOI: 10.1128/AAC.31.2.151. View

12.

Widmer A, Frei R, Rajacic Z, Zimmerli W . Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990; 162(1):96-102. DOI: 10.1093/infdis/162.1.96. View

13.

Widmer A, Gaechter A, Ochsner P, Zimmerli W . Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis. 1992; 14(6):1251-3. DOI: 10.1093/clinids/14.6.1251. View

14.

Gentry L, Rodriguez G . Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother. 1990; 34(1):40-3. PMC: 171517. DOI: 10.1128/AAC.34.1.40. View

15.

Peterson L, Lissack L, Canter K, Fasching C, Clabots C, Gerding D . Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med. 1989; 86(6 Pt 2):801-8. DOI: 10.1016/0002-9343(89)90476-2. View

16.

Seibold R, Betz A . Treatment of posttraumatic osteitis with intravenous ofloxacin. Clin Ther. 1991; 13(4):457-9. View

17.

Greenberg R, Tice A, Marsh P, Craven P, Reilly P, Bollinger M . Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Am J Med. 1987; 82(4A):266-9. View

18.

Chuard C, Herrmann M, Vaudaux P, Waldvogel F, Lew D . Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991; 35(12):2611-6. PMC: 245440. DOI: 10.1128/AAC.35.12.2611. View

19.

Gentry L . Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother. 1991; 35(3):538-41. PMC: 245046. DOI: 10.1128/AAC.35.3.538. View

20.

Yamaguti A, Trevisanello C, Lobo I, Carvalho M, Bortoletto M, Silva M . Oral ciprofloxacin for treatment of chronic osteomyelitis. Int J Clin Pharmacol Res. 1993; 13(2):75-9. View